Zonisamide for the treatment of "off" periods in Japanese patients with Parkinson's disease

Trial Profile

Zonisamide for the treatment of "off" periods in Japanese patients with Parkinson's disease

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2013

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2013 New trial record
    • 20 Jun 2013 Primary endpoint 'Duration-of-treatment-failure' has been met.
    • 20 Jun 2013 Results presented at the 17th International Congress of Parkinson's Disease and Movement Disorders.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top